Rickettsia felis
Rickettsia felis is a species of bacteria in the genus Rickettsia, which belongs to the family Rickettsiaceae. This bacterium is known to cause a disease known as flea-borne spotted fever, which is transmitted to humans through the bite of an infected flea.
Taxonomy[edit]
Rickettsia felis is a member of the genus Rickettsia, which is part of the family Rickettsiaceae. This family is within the order Rickettsiales, which is a group of Gram-negative bacteria. The genus Rickettsia is divided into four groups: the spotted fever group, the typhus group, the ancestral group, and the transitional group. Rickettsia felis falls into the transitional group.
Morphology[edit]
Rickettsia felis is a small, rod-shaped bacterium. Like all Rickettsia species, it is Gram-negative, meaning it does not retain the violet Gram stain used in laboratory testing. Instead, it takes on a red or pink color when stained. This is due to the structure of its cell wall, which has a thin layer of peptidoglycan.
Pathogenesis[edit]
Rickettsia felis is the causative agent of flea-borne spotted fever, also known as cat flea typhus. The disease is transmitted to humans through the bite of an infected flea, most commonly the cat flea (Ctenocephalides felis). Symptoms of the disease include fever, headache, rash, and muscle pain.
Epidemiology[edit]
Flea-borne spotted fever is found worldwide, with cases reported in the Americas, Europe, Africa, and Asia. The disease is most commonly associated with exposure to fleas in domestic settings, particularly where there are cats present.
Treatment and Prevention[edit]
Treatment for flea-borne spotted fever typically involves antibiotics, such as doxycycline or chloramphenicol. Prevention strategies include controlling flea populations in domestic settings and avoiding contact with fleas.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian